Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
39,855 | Dovepress* | 20,031+ | 2,566 | 22,597 | |
PubMed Central* | 19,824 | 3,077 | 22,901 | ||
Totals | 39,855 | 5,643 | 45,498 | ||
*Since 12 November 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
11 | 1 | 0 | 0 | 1 | 9 |
View citations on PubMed Central and Google Scholar